Matches in Nanopublications for { <http://rdf.disgenet.org/nanopublications.trig#NP51893.RA8X_y0JOnVc9EWAwcmVrhcG-ccbA3xgZzPYUICCVMlz4130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP51893.RA8X_y0JOnVc9EWAwcmVrhcG-ccbA3xgZzPYUICCVMlz4130_assertion type Assertion NP51893.RA8X_y0JOnVc9EWAwcmVrhcG-ccbA3xgZzPYUICCVMlz4130_head.
- NP51893.RA8X_y0JOnVc9EWAwcmVrhcG-ccbA3xgZzPYUICCVMlz4130_assertion description "[Genomic DNA was isolated from 214 CTEPH subjects and 200 healthy controls, and analysed for Factor V Leiden, prothrombin guanine (G) to adenine (A) substitution at nucleotide 20210 (20210G>A), plasminogen activator inhibitor-1 4G/5G, tissue plasminogen activator 7351 cytosine (C)>thymidine (T), Factor XIII 100G>T, fibrinogen Aalpha substitution of threonine with alanine at position 312 (Thr312Ala), fibrinogen Bbeta substitution of arginine with lysine at position 448 (Arg448Lys) and fibrinogen Bbeta 455G>A polymorphisms.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP51893.RA8X_y0JOnVc9EWAwcmVrhcG-ccbA3xgZzPYUICCVMlz4130_provenance.
- NP51893.RA8X_y0JOnVc9EWAwcmVrhcG-ccbA3xgZzPYUICCVMlz4130_assertion evidence source_evidence_literature NP51893.RA8X_y0JOnVc9EWAwcmVrhcG-ccbA3xgZzPYUICCVMlz4130_provenance.
- NP51893.RA8X_y0JOnVc9EWAwcmVrhcG-ccbA3xgZzPYUICCVMlz4130_assertion SIO_000772 18057060 NP51893.RA8X_y0JOnVc9EWAwcmVrhcG-ccbA3xgZzPYUICCVMlz4130_provenance.
- NP51893.RA8X_y0JOnVc9EWAwcmVrhcG-ccbA3xgZzPYUICCVMlz4130_assertion wasDerivedFrom gad-20130706 NP51893.RA8X_y0JOnVc9EWAwcmVrhcG-ccbA3xgZzPYUICCVMlz4130_provenance.
- NP51893.RA8X_y0JOnVc9EWAwcmVrhcG-ccbA3xgZzPYUICCVMlz4130_assertion wasGeneratedBy ECO_0000203 NP51893.RA8X_y0JOnVc9EWAwcmVrhcG-ccbA3xgZzPYUICCVMlz4130_provenance.